Parkinson's Foundation releases results of PD Generation study

By The Science Advisory Board staff writers

July 7, 2020 -- The Parkinson's Foundation announced the preliminary results from its Parkinson's Disease (PD) Generation: Mapping the Future of PD pilot study.

The study offered free genetic testing of clinically relevant Parkinson's-related genes and free genetic counseling to help participants better understand their results. The preliminary findings demonstrated the feasibility of conducting comprehensive genetic testing and genetic counseling for the disease and identified rare genetic mutation carriers linked to the disease.

Of the initial 291 individuals tested, 52 (around 17%) tested positive for a genetic mutation that is linked to PD. This is higher than estimates reported in the scientific literature. Moreover, the study revealed that some participants carry multiple mutations and helped identify extremely rare genetic mutations linked to the disease.

The study will continue with the goal of enrolling 15,000 participants in late 2020. The study was temporarily suspended due to the pandemic. The organization has developed a telemedicine-based approach in response to the pandemic whereby participants will be able to enroll in the study using an at-home genetic testing kit and complete virtual genetic counseling sessions.

The Parkinson’s Foundation launches large-scale genetic study, aiming to improve patient care and speed clinical trials
More than 10 million people worldwide are currently living with Parkinson’s disease (PD), a neurodegenerative disorder that impacts the dopamine-producing...
Functionality of small protein determined - potential to develop new therapies for Parkinson’s disease
A small protein, alpha-synuclein, has been found to be associated with the prevention of Parkinson’s disease. Scientists at Oregon Health & Science University...

Copyright © 2020

Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
2020 ACCP Annual Meeting
September 20-22
Bethesda, Maryland United States
Bioprocess International West
September 21-24
Eastern Standard Time Zone (EST) United States
BioProcess International
September 21-24
Eastern Standard Time Zone (EST), Massachusetts United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter